Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)

Product Overview

• Article Name: Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)
• Biozol Catalog Number: ABS-HL1-H82EB-25UG
• Supplier Catalog Number: HL1-H82Eb-25ug
• Alternative Catalog Number: ABS-HL1-H82EB-25UG
• Manufacturer: AcroBiosystems
• Host: Human
• Category: Proteine/Peptide
• Species Reactivity: Human
• Conjugation: Unconjugated

Product Description

Wilms tumor gene 1 (WT1),is an attractive target antigen for leukemia and solid cancer. WT1specific adoptive immunotherapy has developed for tumor treatment in recent years. WT1 has been proved wildly expressed in breast, colon and ovarian cancer. It participates in cell growth, differentiation and apoptosis regulation. The Human HLAA*0201 WT1 (RMFPNAPYL) complex Protein is a complex of HLAA*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT1. - Proteine/Peptide

Product Properties

• Molecular Weight: 36.3 kDa and 11.7 kDa
• Tag: C-10*His & C-Avi
• NCBI: 59606
• Buffer: PBS, pH7.4
• Purity: 90%
• Form: Powder
• Target: HLA-A*0201 & B2M & WT-1 (RMFPNAPYL)

Images

Immobilized Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Cat. No. HL1-H82Eb) at 1 µg/mL (100 µL/well) can bind Monoclonal Anti-HLA class I Antibody, Human IgG1 (W632) with a linear range of 0.06-2 ng/mL (QC tested).

Immobilized Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Cat. No. HL1-H82Eb) at 1 µg/mL (100 µL/well) can bind Monoclonal Anti-B2M Antibody, Human IgG1 with a linear range of 0.06-1 ng/mL (Routinely tested).

Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.